BVT Aktienanleihe OMV 27.06.2025/ DE000VM79F00 /
10/10/2024 19:42:25 | Chg.+0.440 | Bid21:59:14 | Ask21:59:14 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.070EUR | +0.44% | - Bid Size: - |
- Ask Size: - |
OMV AG | 40.00 EUR | 27/06/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center